Zhangzhou Pientzehuang Pharmaceutical., Ltd logo

Zhangzhou Pientzehuang Pharmaceutical., Ltd

600436.SS

Financial Statements

Income Statement (Annual)

Amounts in millions

2024

12/31/2024

Revenue
1,510
Cost of Revenue
866
Gross Profit
644
Gross Margin
42.6%
Operating Income
500
Operating Margin
33.1%
Net Income
417
Net Margin
27.6%
EPS (Basic)
$1.00
EPS (Diluted)
$1.00
EBITDA
486
EBITDA Margin
32.2%

2023

12/31/2023

Revenue
1,408
Cost of Revenue
751
Gross Profit
657
Gross Margin
46.7%
Operating Income
475
Operating Margin
33.7%
Net Income
392
Net Margin
27.8%
EPS (Basic)
$1.00
EPS (Diluted)
$1.00
EBITDA
462
EBITDA Margin
32.8%

2022

12/31/2022

Revenue
1,217
Cost of Revenue
663
Gross Profit
554
Gross Margin
45.5%
Operating Income
417
Operating Margin
34.2%
Net Income
346
Net Margin
28.4%
EPS (Basic)
$1.00
EPS (Diluted)
$1.00
EBITDA
406
EBITDA Margin
33.3%

2021

12/31/2021

Revenue
1,123
Cost of Revenue
556
Gross Profit
568
Gross Margin
50.5%
Operating Income
402
Operating Margin
35.8%
Net Income
340
Net Margin
30.3%
EPS (Basic)
$1.00
EPS (Diluted)
$1.00
EBITDA
400
EBITDA Margin
35.6%

2020

12/31/2020

Revenue
912
Cost of Revenue
502
Gross Profit
410
Gross Margin
44.9%
Operating Income
277
Operating Margin
30.4%
Net Income
234
Net Margin
25.7%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
263
EBITDA Margin
28.9%